For more than a decade, Ralph Thurman has been an operating partner and senior advisor in the private equity industry. He has led several companies as they transition from the private to the public sector and completed more than $2 billion in acquisitions, equity investments, and other transactions across several industries in Europe and North… Continue Reading
Originally published at CityBizList Oncobiologics, Inc. (NASDAQ:ONS) today announced the appointment of Randy Thurman to its board of directors, effective April 13, 2018. At the same time, Oncobiologics also announced the resignation of Scott Canute as director and member of the board of director’s Nominating and Corporate Governance Committee and as Chairman of the Compensation Committee. Mr. Thurman… Continue Reading
Originally published at VLex.com THERE IS SCARCENESS Of ‘ready now’ CEOs to fill the numerous opportunities that exist in many industries (certainly in my industry of healthcare technology and services). As a result, there are many first-time CEOs who lack real board experience. Many are coming from senior executive positions where they may have occasionally… Continue Reading
Originally published at Outsourcing-Pharma.com by Dan Stanton With over 30 years of experience in the health care industry, Randy Thurman has been appointed to Arno Therapeutic’s Board of Directors. Thurman is also Executive Chairman at CogentHMG and previous founded Viasys Healthcare. Glenn Mattes, CEO of Arno, said he was “confident that Mr. Thurman will provide… Continue Reading
Originally published at Post Online Media Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced the appointment of Randy Thurman to its board of directors.With more than 30 years of health care industry experience, Mr. Thurman brings a wealth of operational, financial, and business development expertise to Arno. Mr. Thurman became an Operating Partner for AEA… Continue Reading
Originally published at ModernHealthcare.com CardioNet, a manufacturer of wireless medical-monitoring and diagnostic devices for cardiac arrhythmias, has appointed Randy Thurman as chairman, president and chief executive officer, effective immediately. Thurman, 59, has served as chairman of the Conshohocken, Pa., devicemaker since June 2008 and as interim president and CEO since January 2009, when he replaced… Continue Reading
Originally published at BioTelemetry CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today the Board of Directors has appointed Randy Thurman Chairman, President and Chief Executive Officer, effective immediately. Mr. Thurman has been serving as Chairman of the Board since June 2008 and Interim President and… Continue Reading
Originally published at The Philadelphia Inquirer Medical-device company CardioNet Inc. announces that it has named Randy Thurman chairman, president and chief executive officer, effective immediately. Thurman had been board chairman since June 2008 and interim president and chief executive officer since January. CardioNet is headquartered in Conshohocken. He had more recently been chairman and CEO… Continue Reading
Originally published at ThermoFisher Scientific Viasys Healthcare Inc. (NYSE: VAS-W) announced today that its board of directors has adopted a shareholder rights plan. Under the plan, one right will be distributed today on each share of Viasys Healthcare common stock outstanding at the close of business. Viasys Healthcare adopted the rights plan in anticipation of… Continue Reading
Originally published at ThermoFischer Scientific Thermo Electron Corporation (NYSE: TMO) announced today that it has appointed Randy H. Thurman president and chief executive officer of its new medical products spinoff, Viasys Healthcare Inc., effective April 16. Viasys is a group of wholly owned Thermo Electron medical products businesses, which Thermo Electron intends to spin off… Continue Reading